Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation and management of pulmonary arterial hypertension
Sarah Beshay, Sandeep Sahay, Marc Humbert
Respiratory Medicine (2020) Vol. 171, pp. 106099-106099
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients
Deborah Levine, Stormi E. Gale, Douglas Burgoyne, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 3, pp. S35-S41
Open Access | Times Cited: 64
Contemporary Treatment of Pulmonary Arterial Hypertension: A US Perspective
Sandeep Sahay, Murali M. Chakinala, Nick H. Kim, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 5, pp. 581-592
Closed Access | Times Cited: 8
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis
Jude Moutchia, Robyn L. McClelland, Nadine Al‐Naamani, et al.
European Heart Journal (2024) Vol. 45, Iss. 21, pp. 1937-1952
Closed Access | Times Cited: 7
Consensus recommendations for diagnosis and management of pulmonary arterial hypertension patients in Egypt
Ayman A. Farghaly, Ahmed Abdel Aziz, Reem El Korashy, et al.
Egyptian Journal of Chest Diseases and Tuberculosis (2025) Vol. 74, Iss. Suppl 1, pp. S1-S16
Open Access
Burden of Pulmonary Arterial Hypertension in China from 1990 to 2021, with Projections to 2050: An Analysis of Data from the Global Burden of Disease Study 2021
Shuoshuo Wei, Yonghui Han, Min Liu, et al.
Research Square (Research Square) (2025)
Closed Access
Assessing causal relationships between gut microbiotas, metabolites, and pulmonary arterial hypertension through univariate Mendelian randomization study and bioinformatics analysis
Dongrui Xu, Hong Liu, Jiankang Yang
Journal of Hypertension (2025)
Closed Access
Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies
Fang Cheng, Qiling Xu, Qiang Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKα signaling
Xinyu Deng, Hao Luo, Jing He, et al.
Clinical and Experimental Hypertension (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 4
Clinical Implications and Management of Spontaneous Portosystemic Shunts in Liver Cirrhosis
Simona Juncu, Horia Minea, Irina Gîrleanu, et al.
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1372-1372
Open Access | Times Cited: 4
Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension
Jia-Yong Qiu, Shen-Shen Huang, Chao Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Pulmonary arterial hypertension: a long-standing and nonnegligible burden over three decades
Jiayong Qiu, Lu-Hong Qiu, Shen-Shen Huang, et al.
Science Bulletin (2025)
Closed Access
Insights into the relationship between serum uric acid and pulmonary hypertension (Review)
Yu Zhou, Meihong Chen, Jing Zheng, et al.
Molecular Medicine Reports (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9
An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
Joana Gomes, Inês Gandra, Rui Adão, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 14
SIRT6 inhibits hypoxia-induced pulmonary arterial smooth muscle cells proliferation via HIF-1α/PDK4 signaling
Mingxing Li, Miaofa Ying, Shenglong Gu, et al.
Life Sciences (2022) Vol. 312, pp. 121192-121192
Closed Access | Times Cited: 14
RASA3 is a candidate gene in sickle cell disease‐associated pulmonary hypertension and pulmonary arterial hypertension
Clare C. Prohaska, Xu Zhang, Tae‐Hwi Schwantes‐An, et al.
Pulmonary Circulation (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 8
Evaluation, Diagnosis, and Classification of Pulmonary Hypertension
Sarah Beshay, Ashrith Guha, Sandeep Sahay
Methodist DeBakey Cardiovascular Journal (2021) Vol. 17, Iss. 2, pp. 86-86
Open Access | Times Cited: 20
Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype
William M. Oldham, Edward Hess, Stephen W. Waldo, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 2, pp. 2004625-2004625
Open Access | Times Cited: 18
Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH
Shuyan Zhou, Qiangsheng Zhang, Honglin Yang, et al.
Life Sciences (2024) Vol. 342, pp. 122538-122538
Closed Access | Times Cited: 2
Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress
Yaqin Chai, Xing Gu, Hongjun Zhang, et al.
Aging (2024) Vol. 16, Iss. 6, pp. 5027-5037
Open Access | Times Cited: 2
CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR‐509‐5p/multiple C2 and transmembrane domain containing 2 axis
Xing Zhang, Hao Qin, Qiang Ma, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 5
Open Access | Times Cited: 2
Loss of Tbx4 Affects Postnatal Lung Development and Predisposes to Pulmonary Hypertension.
Gabriel Maldonado-Velez, Elizabeth A. Mickler, Todd Cook, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Pulmonary Artery Denervation as a New Therapeutic Option for Pulmonary Hypertension: A Systematic Review and Meta-Analysis
Adolfo Martinez Salazar, Khalid Saeed Al-Asad, Rohan Prasad, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101776-101776
Closed Access | Times Cited: 6
Portopulmonary hypertension: A focused review for the internist
Mamta Chhabria, Leela Krishna Teja Boppana, Gaurav Manek, et al.
Cleveland Clinic Journal of Medicine (2023) Vol. 90, Iss. 10, pp. 632-639
Open Access | Times Cited: 6
Matrine alleviates hypoxia‐induced inflammation and pulmonary vascular remodelling via RPS5/NF‐κB signalling pathway
Mingxing Li, Miaofa Ying, Shenglong Gu, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Reducing economic burden and improving quality of life in pulmonary arterial hypertension
Deborah Levine, Stormi E. Gale, Douglas Burgoyne, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 3, pp. S53-S58
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top